Compare TAVEXIA LIFECARE with Similar Stocks
Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -0.24
- The company has been able to generate a Return on Equity (avg) of 5.09% signifying low profitability per unit of shareholders funds
Risky - Negative EBITDA
Stock DNA
Retailing
INR 40 Cr (Micro Cap)
NA (Loss Making)
21
0.00%
0.05
1.55%
0.91
Total Returns (Price + Dividend) 
TAVEXIA LIFECARE for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Broad-Based Technical Strength Lifts Sattva Sukun Lifecare Ltd to 52-Week High of Rs 1.14
Surging to a fresh 52-week high of Rs 1.14 on 27 Aug 2026, Sattva Sukun Lifecare Ltd has demonstrated remarkable price momentum, outperforming its retailing sector peers and the broader market. This milestone caps a three-day rally that has delivered nearly 46% returns, underscoring the stock’s strong technical positioning amid a mixed market backdrop.
Read full news article
Broad-Based Technical Strength Lifts Sattva Sukun Lifecare Ltd to 52-Week High of Rs 1.05
With a decisive break above its previous highs, Sattva Sukun Lifecare Ltd surged to a new 52-week peak of Rs 1.05 on 26 Aug 2026, marking a significant milestone in its price momentum. This advance comes amid a broader market rally, with the Sensex trading 0.4% higher and several midcap indices also hitting fresh highs.
Read full news article
Sattva Sukun Lifecare Ltd Upgraded to Sell Amid Mixed Technical and Financial Signals
Sattva Sukun Lifecare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 25 August 2026, driven primarily by a marked improvement in technical indicators. Despite this positive shift, the company continues to face significant fundamental challenges, including operating losses and weak long-term financial metrics. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that influenced the recent rating change.
Read full news article Announcements 
Announcement Under Regulation 30
26-Aug-2026 | Source : BSEAnnouncement under regulation 30
Announcement under Regulation 30 (LODR)-Change of Company Name
20-Aug-2026 | Source : BSEIntimation for change of Name from Sattva Sukun Lifecare Limited to Tavexia Lifecare Limited.
Announcement under Regulation 30 (LODR)-Newspaper Publication
05-Aug-2026 | Source : BSENewspaper publication of first quarter ended un-audited financial result .
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
TAVEXIA LIFECARE LIMITED has announced 1:5 stock split, ex-date: 25 Oct 24
TAVEXIA LIFECARE LIMITED has announced 3:5 bonus issue, ex-date: 17 Jan 25
TAVEXIA LIFECARE LIMITED has announced 5:2 rights issue, ex-date: 09 May 25
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 0 FIIs
Roshan Dealmark Private Limited (6.37%)
L7 Hitech Private Limited (6.68%)
72.45%
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
QoQ Growth in quarter ended Jun 2026 is -92.47% vs 49.38% in Mar 2026
QoQ Growth in quarter ended Jun 2026 is 75.00% vs 10.00% in Mar 2026
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 699.12% vs 115.24% in Sep 2024
Growth in half year ended Sep 2025 is 37.50% vs 174.29% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 462.80% vs 64.20% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -44.24% vs 126.03% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 513.12% vs 48.17% in Mar 2025
YoY Growth in year ended Mar 2026 is -95.58% vs 109.24% in Mar 2025






